Algorae Pharmaceuticals Limited (FRA:LHI0)

Market Cap	13.49M +133.2%
Revenue (ttm)	n/a
Net Income	-576.14K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0045
Previous Close	0.0045
Day's Range	0.0045 - 0.0045
52-Week Range	0.0010 - 0.0160
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Algorae Pharmaceuticals

Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand. The company’s product pipeline includes AI-116, a novel combination drug candidate made up of donepezil and cannabidiol for the treatment of dementia, including Alzheimer’s disease; AI-168, a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient for the treatment of cardiovascular disease, such as hypertension; and NTCELL, an alginate...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1987
• Employees: 48
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: LHI0

Financial Performance

Financial numbers in AUD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error